Max Robotics — Global Service Robot Directory + US Certification

About

Tiffany A. Glazer is a surgeon-researcher whose work has significantly advanced the surgical management of obstructive sleep apnea (OSA), with a particular focus on transoral robotic surgery (TORS) as an innovative treatment modality. Her research has helped establish TORS as a viable and effective intervention for patients with moderate-to-severe obstructive sleep apnea hypopnea syndrome (OSAHS), contributing critical evidence to a field historically reliant on more invasive approaches. Glazer's most influential contributions include large-scale evaluations of perioperative outcomes and complication profiles in TORS patients, work that collectively has garnered over 140 citations. Her 2014 studies laid foundational groundwork by demonstrating acceptable surgical morbidity and identifying body mass index as a key predictor of surgical success — findings with direct clinical implications for patient selection. Her subsequent investigation into drug-induced sleep endoscopy (DISE) explored its utility in predicting surgical outcomes, while her Friedman stage stratification work refined patient classification and outcome expectations. Together, these contributions have helped clinicians better identify ideal surgical candidates, optimize multilevel procedural approaches, and improve overall outcomes for sleep apnea patients — making Glazer a meaningful voice in the evolving landscape of robotic sleep surgery.